BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 7879653)

  • 1. TCA-100 tumour chemosensitivity assay: differences in sensitivity between cultured tumour cell lines and clinical studies.
    Andreotti PE; Linder D; Hartmann DM; Cree IA; Pazzagli M; Bruckner HW
    J Biolumin Chemilumin; 1994; 9(6):373-8. PubMed ID: 7879653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma.
    Andreotti PE; Cree IA; Kurbacher CM; Hartmann DM; Linder D; Harel G; Gleiberman I; Caruso PA; Ricks SH; Untch M
    Cancer Res; 1995 Nov; 55(22):5276-82. PubMed ID: 7585588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of culture conditions on the chemosensitivity of ovarian cancer cell lines.
    Fernando A; Glaysher S; Conroy M; Pekalski M; Smith J; Knight LA; Di Nicolantonio F; Cree IA
    Anticancer Drugs; 2006 Sep; 17(8):913-9. PubMed ID: 16940801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between ATP bioluminescence tumor chemosensitivity assay and clinical response in ovarian cancer].
    Tian HM; Shi XY; Fu J; Chao DY; Zhang K; Wu LY; Wang JW; Zhang W
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):296-8. PubMed ID: 15996325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [-Chemosensitivity testing in gynecologic oncology. Experiences with an ATP bioluminescence assay-].
    Kurbacher CM; Mallmann P; Kurbacher JA; Hübner H; Krebs D
    Geburtshilfe Frauenheilkd; 1996 Feb; 56(2):70-8. PubMed ID: 8647362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements.
    Kurbacher CM; Cree IA
    Methods Mol Med; 2005; 110():101-20. PubMed ID: 15901931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro chemosensitivity in breast cancer using ATP-tumor chemosensitivity assay.
    Qi CJ; Ning YL; Zhu YL; Min HY; Ye H; Qian KQ
    Arch Pharm Res; 2009 Dec; 32(12):1737-42. PubMed ID: 20162402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
    Konecny G; Crohns C; Pegram M; Felber M; Lude S; Kurbacher C; Cree IA; Hepp H; Untch M
    Gynecol Oncol; 2000 May; 77(2):258-63. PubMed ID: 10785475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Basic study on in vitro chemosensitivity tests].
    Iijima N; Sekiya S; Tokita H; Takamizawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Feb; 43(2):191-6. PubMed ID: 2013708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro assays of chemotherapeutic sensitivity.
    Carney DN; Winkler CF
    Important Adv Oncol; 1985; ():78-103. PubMed ID: 3916747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The evaluation of adenosine triphosphate bioluminescence assay for chemosensitivity testing of ovarian cancer cell line].
    Shi W; Gu M; Liang L
    Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):79-82. PubMed ID: 8758798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of chemosensitivity in human breast carcinoma: use of an adenosine triphosphate (ATP) chemiluminescence assay.
    Hunter EM; Sutherland LA; Cree IA; Dewar JA; Preece PE; Wood RA; Linder D; Andreotti PE
    Eur J Surg Oncol; 1993 Jun; 19(3):242-9. PubMed ID: 8314382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cell proliferation and cell death based assays in chemosensitivity testing.
    Gerçel-Taylor C; Ackermann MA; Taylor DD
    Anticancer Res; 2001; 21(4A):2761-8. PubMed ID: 11724352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer.
    O'Meara AT; Sevin BU
    Gynecol Oncol; 2001 Nov; 83(2):334-42. PubMed ID: 11606094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of a micromethod in ovarian cancer chemosensitivity testing in vitro].
    Liu S; Qian X; Peng Z; Wang H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):298-9, 312. PubMed ID: 12947719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemosensitivity testing: a critical review.
    Cramer AB; Woltering EA
    Crit Rev Clin Lab Sci; 1991; 28(5-6):405-13. PubMed ID: 1772587
    [No Abstract]   [Full Text] [Related]  

  • 17. A radiometric method for evaluation of chemotherapy sensitivity: results of screening a panel of human breast cancer cell lines.
    Arteaga CL; Forseth BJ; Clark GM; Von Hoff DD
    Cancer Res; 1987 Dec; 47(23):6248-53. PubMed ID: 3119196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro drug resistance versus chemosensitivity: two sides of different coins.
    Fruehauf JP; Alberts DS
    J Clin Oncol; 2005 May; 23(15):3641-3; author reply 3646-8. PubMed ID: 15908686
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemosensitivity and chemoresistance testing in ovarian cancer.
    Cree IA
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):39-43. PubMed ID: 19125002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing of a chemosensitivity screening method on sensitive and resistant breast tumoral epithelial cell lines.
    Colomb E; Martin PM
    Anal Cell Pathol; 1994 Feb; 6(2):105-16. PubMed ID: 8167093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.